WASHINGTON DC: The research published in the journal PLOS Biology says that melatonin, which is a sleep-wake regulating hormone, can be a potential aid for COVID-19 patients. Melatonin is used as an over-the-counter sleep aid. The study used novel Artificial Intelligence (AI) platform to identify possible drugs for COVID-19 repurposing.
Examination of patient data from United States of America (USA) based Cleveland Clinic revealed that melatonin reduced the risk of exposure to novel coronavirus by almost 30 per cent. The researchers said that the percentage improved from 30 to 52 per cent for African-Americans when adjusted for same variables.
Feixiong Cheng, Assistant Staff, Cleveland Clinic, said that the findings do not suggest that people take melatonin without expert supervision. He added that observational studies on a large scale and randomised controlled trials are important to validate the effect of melatonin on COVID-19. This points towards the possibility that a drug, that is already approved to treat respiratory problems, may have some use in treating COVID-19.
The study provides a strong and integrative network medicine strategy to predict disease manifestations associated with COVID-19 and facilitate the search for an effective treatment, he added.
Representative Image NEW DELHI: The India Meteorological Department (IMD) has issued a warning regarding an…
Representative Image JAMMU and KASHMIR: The National Green Tribunal (NGT) has called upon the Central…
Representative Image NEW DELHI: The 19th edition of the United Nations Forum on Forests (UNFF…
Representative Image MUMBAI, Maharashtra: The Brihanmumbai Municipal Corporation (BMC) has published a list of 188…
Representative Image CHENNAI, Tamil Nadu: The Greater Chennai Municipal Corporation is mulling the plan to…
Representative Image TRICHIRAPALLI, Tamil Nadu: Faulty Streetlights on the newly built Kollidam Bridge in Trichy…